<?xml version="1.0" encoding="UTF-8"?>
<ref id="b94-cep-2020-00759">
 <label>94</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chiotos</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Hayes</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Kimberlin</surname>
    <given-names>DW</given-names>
   </name>
   <name>
    <surname>Jones</surname>
    <given-names>SB</given-names>
   </name>
   <name>
    <surname>James</surname>
    <given-names>SH</given-names>
   </name>
   <name>
    <surname>Pinninti</surname>
    <given-names>SG</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2</article-title>
  <source>J Pediatric Infect Dis Soc</source>
  <comment>2020 Apr 22:piaa045. </comment>
  <pub-id pub-id-type="doi">10.1093/jpids/piaa045</pub-id>
 </element-citation>
</ref>
